SCHEMBL29588955

SCHEMBL29588955

COCCNC(=O)c1cccc(-c2cc(Cl)c(C)cc2O)c1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 4/20 0.54
▸ TNKS2 Q9H2K2 1/20 0.50
▸ GPR52 Q9Y2T5 2/20 0.48
▸ TP53 P04637 1/20 0.47
▸ KMT2A Q03164 3/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ MRGPRX4 Q96LA9 1/20 0.45
▸ KDM4E B2RXH2 2/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ SMYD2 Q9NRG4 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ CA2 P00918 1/20 0.44
▸ ERN1 O75460 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18618141 1.00 HPGD (0.54) HPGDTNKS2GPR52TP53KMT2A
SCHEMBL18617224 0.89 SMN1; SMN2 (0.44) HPGDTNKS2KMT2AMEN1KDM4E
SCHEMBL18618089 0.88 POLB (0.50) HPGDGPR52KMT2AMEN1SMYD2
SCHEMBL22579135 0.86 SMN1; SMN2 (0.59) HPGDMRGPRX4SMYD2GAAMAPT
SCHEMBL20056615 0.82 HPGD (0.58) HPGDTNKS2GPR52TP53MRGPRX4
SCHEMBL18618319 0.82 MAPK1 (0.46) HPGDTP53KDM4EMAPK1GAA
SCHEMBL18617225 0.81 ERN1 (0.51) KMT2AMEN1MAPTCA2ERN1
SCHEMBL22579136 0.79 HPGD (0.47) HPGDTP53KMT2AMEN1LMNA
SCHEMBL15959008 0.77 HPGD (0.55) HPGDKMT2AMEN1KDM4EMAPK1
SCHEMBL18618116 0.77 NR1H4 (0.59) HPGDKMT2AMEN1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11352330-B2 Phenoxymethyl derivatives HOFFMANN-LA ROCHE INC. (US) 2022-06-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11352330-B2 Phenoxymethyl derivatives CNKSR1, RB1, RCOR1 HPGD 2706/4885TNKS2 1409/4885GPR52 1896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback